Related references
Note: Only part of the references are listed.(D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer's disease transgenic mice
Guang-Zhao Yang et al.
NEURAL REGENERATION RESEARCH (2022)
Liposome based drug delivery as a potential treatment option for Alzheimer's disease
Carely Hernandez et al.
NEURAL REGENERATION RESEARCH (2022)
Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease
Jeffrey Cummings
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2021)
Action Mechanisms of Curcumin in Alzheimer's Disease and Its Brain Targeted Delivery
Duygu Ege
MATERIALS (2021)
Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
Divya Gopalan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Brain microRNAs dysregulation: Implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies
Maryam Bazrgar et al.
PHARMACOLOGICAL RESEARCH (2020)
Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological Disorders
Saurabh Mittal et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Biological properties and clinical applications of berberine
Danyang Song et al.
FRONTIERS OF MEDICINE (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Drug repositioning and repurposing for Alzheimer disease
Clive Ballard et al.
NATURE REVIEWS NEUROLOGY (2020)
Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
Alba Calvo et al.
PHARMACEUTICS (2020)
Involvement of endoplasmic reticulum stress in amyloid β (1-42)-induced Alzheimer's like neuropathological process in rat brain
Poonam Goswami et al.
BRAIN RESEARCH BULLETIN (2020)
Alzheimer's disease drug development pipeline: 2020
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies
Ning-Ning Yuan et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice
Dafeng Bai et al.
JOURNAL OF PHYSIOLOGICAL SCIENCES (2019)
Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice
Avinash Gothwal et al.
BIOCONJUGATE CHEMISTRY (2019)
Therapeutic potential and recent delivery systems of berberine: A wonder molecule
Marina Raju et al.
JOURNAL OF FUNCTIONAL FOODS (2019)
Fluorescence Imaging of Alzheimer's Disease with a Flat Ensemble Formed between a Quinoline-Malononitrile AIEgen and Thin-Layer Molybdenum Disulfide
Wei-Tao Dou et al.
CHEMBIOCHEM (2019)
Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement
Zahra Karami et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms
Sepideh Sadraie et al.
METABOLIC BRAIN DISEASE (2019)
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Ying Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Nano strategies for berberine delivery, a natural alkaloid of Berberis
Elaheh Mirhadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Estrogen-related receptor alpha is involved in Alzheimer's disease-like pathology
Ying Tang et al.
EXPERIMENTAL NEUROLOGY (2018)
Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MSbased drug biodistribution, pharmacodynamics, and neuroprotective effects
Xiuju Yan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease
Qingqing Meng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine
Chaoyue Zhao et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)
PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure
Lingxuan Mo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma
Shuang Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease
Min Huang et al.
EXPERIMENTAL GERONTOLOGY (2017)
Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction
Iris E. Allijn et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Preparation, pharmacokinetics and tumour-suppressive activity of berberine liposomes
Xinghui Wang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease
J. Chu et al.
MOLECULAR PSYCHIATRY (2017)
Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation
Wenbo He et al.
PHARMACOLOGICAL REPORTS (2017)
Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
Qingjie Chen et al.
FRONTIERS IN PHARMACOLOGY (2017)
Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review
Yingying Jiang et al.
BIOORGANIC CHEMISTRY (2017)
Alzheimer's Disease: Targeting the Cholinergic System
Talita H. Ferreira-Vieira et al.
CURRENT NEUROPHARMACOLOGY (2016)
Old and new acetylcholinesterase inhibitors for Alzheimer's disease
Daniela Galimberti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice
Ge Jin et al.
NEUROSCIENCE LETTERS (2016)
Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death
Juliana Sorraila de Oliveira et al.
NEUROTOXICOLOGY (2016)
New Developments in Liposomal Drug Delivery
Bhushan S. Pattni et al.
CHEMICAL REVIEWS (2015)
In vivo rapid fluorescence imaging of Alzheimer's disease through accurate target bio-marking of zinc gluconate
Lanmei Lai et al.
SCIENCE BULLETIN (2015)
Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1-42
Xue-Fei Ji et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery
Feng-Yun J. Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model
Yung-Chang Lin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Preparation of berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method
Xiang Luo et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model
Siva Sundara Kumar Durairajan et al.
NEUROBIOLOGY OF AGING (2012)
Advances in the Pathogenesis of Alzheimer's Disease: Focusing on Tau-Mediated Neurodegeneration
Yale Duan et al.
TRANSLATIONAL NEURODEGENERATION (2012)
Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1
Ben A. Croker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Highly Sensitive Protein Concentration Assay over a Wide Range via Surface-Enhanced Raman Scattering of Coomassie Brilliant Blue
Xiao Xia Han et al.
ANALYTICAL CHEMISTRY (2010)
Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation
Chiraz Jaafar-Maalej et al.
JOURNAL OF LIPOSOME RESEARCH (2010)
Conformation-activity studies on the interaction of berberine with acetylcholinesterase: Physical chemistry approach
Jin Xiang et al.
PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL (2009)
Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain
Rong-qin Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2007)
Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target
Cheng-Xin Gong et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Mammalian lactoferrin receptors:: structure and function
YA Suzuki et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation
F Liu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Share Paper
